Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.
22nd Century Group Inc. develops and commercializes reduced-nicotine tobacco products built on proprietary plant biotechnology. Its VLN® combustible cigarette products use low-nicotine tobacco and are described in company materials as FDA-authorized reduced nicotine cigarettes in the United States. Company updates commonly address VLN retail distribution, state authorizations, PMTA-related product expansion, licensing strategy, tobacco-variety research and engagement with FDA and public-health stakeholders.
News also covers operating results for the tobacco business, including branded VLN products, contract manufacturing volumes, filtered cigars and other distributed tobacco products. Recent company reporting frames results around commercial expansion, cost management, higher-margin branded products and the completed exit from the hemp/cannabis business.
22nd Century Group (Nasdaq: XXII) will report fourth quarter and full year 2025 results on March 26, 2026, issuing a press release at 6:00 AM ET and hosting a live webcast at 8:00 AM ET.
Chairman and CEO Larry Firestone and CFO Dan Otto will review results, discuss recent progress and outline 2026 plans. The live and archived webcast will be available on the company's Events page at https://ir.xxiicentury.com/events.
22nd Century Group (Nasdaq: XXII) reported early commercial traction for its FDA-authorized VLN® low nicotine combustible cigarettes. In Q4 2025 the company distributed ~8,800 cartons across ~1,700 new retail outlets, and plans to exceed 5,000 retail points in 2026.
The release cites FDA regulatory developments (Jan 2025 proposed 0.7 mg/g nicotine cap) and reiterates VLN® authorization in Dec 2021 as supporting the company’s market opportunity and distribution expansion.
22nd Century Group (Nasdaq: XXII) preliminarily reported fourth-quarter and full-year 2025 results. Key figures: 2025 revenue $17.6M (down from $24.4M in 2024), 2025 net loss $13.1M, cash $7.1M at year-end and zero long-term debt. Inventory rose to $4.3M.
The company expects audited results on or before March 31, 2026, and will host a conference call. Results are preliminary and subject to year-end audit adjustments.
22nd Century Group (Nasdaq: XXII) issued a 2025 year-in-review letter from CEO Lawrence Firestone highlighting the company’s exit from a multi-year restructuring, relaunch of its VLN® reduced-nicotine cigarette platform, and strengthened balance sheet.
Key facts: VLN® contains ~95% less nicotine, is the only FDA-authorized MRTP combustible cigarette, VLN® relaunched in 2025 and is now in ~2,000 retail locations across 20+ states, and the company eliminated debt and improved liquidity while targeting EBITDA breakeven as higher-margin VLN® sales scale.
22nd Century (Nasdaq: XXII) announced that CEO Larry Firestone and CFO Dan Otto will present at the Needham Growth Conference on January 16, 2026. The management team will be available for virtual one-on-one meetings for investors. Interested parties can register through their Needham representative or contact investor relations at investorrelations@xxiicentury.com to arrange meetings.
22nd Century Group (Nasdaq: XXII) filed a Modified Risk Tobacco Product (MRTP) renewal on Jan 6, 2026 for its VLN® reduced nicotine combustible cigarettes, the only combustible cigarette authorized by the FDA to make low‑nicotine and "helps you smoke less" claims.
Key factual points: VLN® tobacco contains 95% less nicotine; a 2024 marketplace study reported a 40% reduction in daily smoking over 12 weeks; original FDA authorization was issued in Dec 2021 for five years, with renewal due Dec 2026.
22nd Century Group (Nasdaq: XXII) announced that CEO Larry Firestone will present at the Emerging Growth Virtual Investor Conference on Wednesday, December 10, 2025 at 3:55 PM ET.
Investors can register to attend the live webcast and submit questions in advance; an archived webcast will be posted in the Events section of the company's investor relations website if attendees cannot join live.
Background: 22nd Century develops proprietary non‑GMO reduced‑nicotine tobacco (reported as 95% less nicotine vs traditional tobacco) and markets the FDA‑authorized VLN® combustible cigarette.
22nd Century Group (Nasdaq: XXII) announced receipt of $9.5 million in cash proceeds from a settlement with its insurer for business interruption related to the Grass Valley incident (November 2022).
Company leadership said the settlement strengthens the balance sheet and supports a shift from cleanup into a growth phase focused on expanding its core VLN® reduced-nicotine cigarette business. The release reiterates that VLN products contain 95% less nicotine and that the VLN cigarette is the only low-nicotine combustible cigarette authorized by the FDA in the United States.
22nd Century Group (NASDAQ: XXII) announced on Oct 23, 2025 that its VLN® reduced-nicotine cigarettes will begin sales at approximately 140 Circle K locations in Illinois. VLN® products are now authorized for sale in 45 states, with five states pending, and the company unveiled new marketing and consumer-education materials covering its VLN® combustible cigarette lineup.
The company highlights that its proprietary VLN® tobacco contains 95% less nicotine and that VLN® is the first and only combusted cigarette product authorized by the FDA under the agency's low-nicotine framework.
22nd Century Group (Nasdaq: XXII) will report third quarter 2025 results on November 4, 2025. The company will issue a press release at 6:00 AM ET and host a live webcast at 8:00 AM ET with CEO Larry Firestone and CFO Dan Otto reviewing financial results, recent progress, and 2025 plans.
The company highlights its VLN® combustible cigarette containing 95% less nicotine and notes VLN® is the only low‑nicotine combustible cigarette authorized by the FDA in the U.S. Investors can access the live and archived webcast via the company Events page at https://ir.xxiicentury.com/events.